Infrared, Visible Light, Or Ultraviolet Radiation Directed On Or Through Body Or Constituent Released Therefrom Patents (Class 600/310)
  • Patent number: 8290557
    Abstract: An implantable medical device includes a hermetically sealed housing and a first light emitting diode (LED) enclosed within the housing configured to detect light corresponding to a selected light wavelength. A conductive element extends from the LED for carrying a current signal corresponding to the light detected by the LED, the intensity of the detected light being correlated to a change in a physiological condition in a body fluid volume or a tissue volume proximate the LED.
    Type: Grant
    Filed: December 12, 2007
    Date of Patent: October 16, 2012
    Assignee: Medtronic, Inc.
    Inventors: Timothy J. Davis, Jonathan P. Roberts, James D. Reinke, Jonathan L. Kuhn, Shawn D. Knowles
  • Patent number: 8285353
    Abstract: The present invention relates, in general, to a system for analyzing tissue perfusion using the concentration of indocyanine green and a method of measuring the perfusion rate using the system and, more particularly, to a system for measuring tissue perfusion by injecting indocyanine green into a living body, detecting variation in the concentration of indocyanine green with the passage of time, and analyzing the detected variation, and a method of measuring the perfusion rate using the system. The present invention provides a method of measuring perfusion in a living body, which enables accurate measurement for respective regions in a wide range from a perfusion rate decreased to less than 10% of normal perfusion to a perfusion rate increased to greater than normal perfusion using the above-described mechanism of ICG in a living body, which cannot be conducted using the conventional technology.
    Type: Grant
    Filed: July 11, 2007
    Date of Patent: October 9, 2012
    Assignee: Korea Advanced Institute of Science and Technology
    Inventors: Chulhee Choi, Yujung Kang, Myunghwan Choi
  • Patent number: 8285003
    Abstract: A personal authentication method comprising imaging, on an image sensor as a laser speckle using an optical system, light reflected from retinal blood vessels of the ocular fundus and a blood vessel layer in ocular fundus internal tissue when a laser beam is expanded and made to irradiate the ocular fundus, calculating a quantity that represents the rate of change with respect to time of the amount of light received for each pixel of the laser speckle, obtaining an ocular fundus blood flow map as a two-dimensional map of the numerical values of the quantity, and comparison-checking against pre-registered personal data utilizing at least one, observed in the blood flow map, of blood flow distribution data, a pattern reflecting the course of retinal blood vessels, a pattern reflecting the course of blood vessels in ocular fundus internal tissue observed superimposed thereon, and data on changes thereof over time, and a device therefor.
    Type: Grant
    Filed: May 28, 2007
    Date of Patent: October 9, 2012
    Assignees: Kyushu Institute of Technology, Syscom Japan, Inc.
    Inventors: Hitoshi Fujii, Naoki Konishi
  • Publication number: 20120253148
    Abstract: The present disclosure relates to sensors for use on a patient's ear. The sensors as provided may be disposable and configured to be retained on an ear with a biasing mechanism. In particular embodiments, the biasing mechanism is a sliding clip that is configured to bias a first portion and a second portion of a sensor body towards one another.
    Type: Application
    Filed: March 31, 2011
    Publication date: October 4, 2012
    Applicant: Nellcor Puritan Bennett LLC
    Inventors: Charles Haisley, David Besko
  • Publication number: 20120253147
    Abstract: A calibration method for an apparatus for non-invasively monitoring blood characteristics of a subject is disclosed. The apparatus is provided with a computational model representing a relationship between in-vivo measurement signals obtained from the subject and the blood characteristics. The providing includes employing at least one tissue property variable in the computational model, in which the at least one tissue property variable is indicative of absorption and scattering characteristics of the subject's tissue. An arrangement for determining blood characteristics of a subject and a sensor for the arrangement are also disclosed.
    Type: Application
    Filed: March 31, 2011
    Publication date: October 4, 2012
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Matti Huiku, Antti Tolonen, Victor Petrovich Ostroverkhov, Katja Urpalainen
  • Publication number: 20120253146
    Abstract: A system and method for determining physiological parameters of a patient based on light transmitted through the patient. A light drive signal may be generated by an audio codec in a processor and utilized to generate the light transmitted through the patient. Additionally, the processor may calculate physiological parameters of the patient based on digital data signals converted in the audio codec that are indicative of absorption of light in the patient.
    Type: Application
    Filed: March 30, 2011
    Publication date: October 4, 2012
    Applicant: Nellcor Puritan Bennett LLC
    Inventor: Daniel Lisogurski
  • Publication number: 20120253149
    Abstract: A non-invasive method and apparatus utilizing a single wavelength (800 nm, isobestic) for the instantaneous, reflective, non-pulsatile spatially resolved reflectance system, apparatus and mathematics that allows for the correct determination of critical photo-optical parameters in vivo. Transcutaneous blood constituent (analyte or drug level) measurements can be determined in real-time. The “closed-form” nature of the mathematics allows for immediate calculations and real-time display of Hematocrit and other pertinent blood values in a variety of handheld or other like devices.
    Type: Application
    Filed: March 26, 2012
    Publication date: October 4, 2012
    Inventor: Robert STEUER
  • Publication number: 20120253153
    Abstract: The present disclosure relates generally to medical devices and, more particularly, to optical medical sensors used for sensing physiological characteristics of a patient. In one embodiment, a system includes a physiological sensor having a photodetector array with a plurality of photodetectors configured to receive light from patient tissue. The physiological sensor also includes a multiplexor configured select and output a signal from the photodetector array. The physiological sensor may also include a signal analyzer configured to determine the signal quality for each of the output signals of the photodetector array and select an output signal, based on the signal quality determination, for the calculation of a physiological parameter of the patient. In another embodiment, a system includes a pulse oximetry sensor having a multiplexed array of photodetectors configured to receive light from patient tissue.
    Type: Application
    Filed: March 31, 2011
    Publication date: October 4, 2012
    Applicant: Nellcor Puritan Bennett LLC
    Inventor: David Trumble
  • Patent number: 8280472
    Abstract: A method and apparatus are disclosed for measuring blood oxygen saturation by using spectrophotometry to improve the accuracy of the measurement under a condition of low perfusion.
    Type: Grant
    Filed: December 27, 2007
    Date of Patent: October 2, 2012
    Assignee: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    Inventors: Xu Li, Xu Zhang
  • Patent number: 8280469
    Abstract: A method is provided for determining contact of a sensor with a patient's tissue. The method comprises comparing the intensity of detected light at a first wavelength to a threshold, wherein the first wavelength is not used to determine a physiological characteristic of the patient, and determining if the sensor is in contact with the patient's tissue based on the comparison. In addition, a method is provided for determining the amount of light shunting during operation of the sensor. The method comprises comparing the intensity of detected light at a first wavelength to a threshold, wherein the first wavelength is not used to determine a physiological characteristic of the patient, and determining the amount of light shunting based on the comparison.
    Type: Grant
    Filed: March 9, 2007
    Date of Patent: October 2, 2012
    Assignee: Nellcor Puritan Bennett LLC
    Inventor: Clark R. Baker, Jr.
  • Patent number: 8279443
    Abstract: A bioinstrumentation apparatus irradiates light onto a measured region of a subject, detects diffused light to acquire internal information on the measured region, and includes: a container holding a light transmitting medium; a light irradiation unit including a plurality of light emitting ends fixed to the container and irradiating a first light and a second light that mutually differ in wavelength onto the measured region that is immersed in the medium; a light detection unit including a plurality of light detecting ends fixed to the container and detecting the diffused light from the measured region; and a computing unit computing the internal information based on an output signal from the light detection unit; the wavelength of the first light being a wavelength at which an absorption coefficient of the measured region and a mean value of absorption coefficient of the medium are substantially equal, the wavelength of the second light being a wavelength at which the absorption coefficient of the measured
    Type: Grant
    Filed: October 10, 2008
    Date of Patent: October 2, 2012
    Assignee: Hamamatsu Photonics K.K.
    Inventors: Yukio Ueda, Yutaka Yamashita
  • Patent number: 8280470
    Abstract: The invention generally relates to systems, methods, and apparatuses for an analyte sensor. In one aspect, an analyte sensing device comprises a sensor body member including at least one nanopore and an optical conduit in optical communication with the sensor body member. The optical conduit transmits optical energy to the sensor body member and receives reflected optical energy back from the sensor body member. A photodetector is optically coupled to the optical conduit to determine an optical parameter from the reflected optical energy.
    Type: Grant
    Filed: November 5, 2007
    Date of Patent: October 2, 2012
    Assignee: Volcano Corporation
    Inventors: Thomas E. Milner, Nathaniel J. Kemp, Paul Castella
  • Patent number: 8280484
    Abstract: Systems, devices, and methods are described for detecting an embolus, thrombus, or a deep vein thrombus in a biological subject.
    Type: Grant
    Filed: April 30, 2009
    Date of Patent: October 2, 2012
    Inventors: Edward S. Boyden, Eric C. Leuthardt
  • Patent number: 8280471
    Abstract: Disclosed are methods and devices for continuous in vivo monitoring of a potential bacterial infection site. Disclosed devices may be utilized to alert patients and/or health care providers to the presence of pathogenic bacteria at an early stage of a hospital acquired infection, thereby providing for earlier intervention. Disclosed methods utilize optical fibers to deliver an excitation signal to an area in which pathogenic bacteria may exist. In the presence of the excitation signal, bacterial pathogens may autofluoresce with a unique spectral signature. Upon generation of a fluorescent emission, an optically detectable emission signal may be transmitted to a detection/analysis device. Analysis of the characteristics of the emission signal produced in response to the excitation signal may be used to determine the presence or concentration of pathogens at the site of inquiry, following which real time information may be transmitted to medical personnel via a wireless transmission system.
    Type: Grant
    Filed: December 12, 2007
    Date of Patent: October 2, 2012
    Assignee: Kimberly-Clark Worldwide, Inc.
    Inventors: Mike Rainone, Erica M. Phillips, Richard Hantke, Shawn R. Feaster, Daniel Baird, Thomas Edward Plowman, Talbot Presley
  • Patent number: 8280473
    Abstract: An embodiment of the present disclosure seeks to smooth a perfusion index measurement through use of a baseline perfusion index measurement and/or through the use of multiple PI calculations. The combination of the baseline perfusion index measurement reduces an error between a calculated measurement of PI and actual conditions.
    Type: Grant
    Filed: October 12, 2007
    Date of Patent: October 2, 2012
    Assignee: Masino Corporation, Inc.
    Inventor: Ammar Al-Ali
  • Publication number: 20120245440
    Abstract: The invention provides high speed, low cost scanning suitable for time domain OCT systems. According to the preferred embodiment, the apparatus includes a piezo scanning device and partial reflecting surfaces that simultaneously generate two sets of multiple reference signals at two different wavelengths that can span different regions of a target enabling acquiring target information from a large range within the target. In one embodiment of the invention, information from both the front region and the back region of an eye is acquired in a coordinated manner.
    Type: Application
    Filed: March 24, 2012
    Publication date: September 27, 2012
    Inventor: Josh N. HOGAN
  • Publication number: 20120245439
    Abstract: A physiological measuring system is disclosed that monitors certain physiological parameters of an individual through the use of a body-mounted sensing apparatus. The apparatus is particularly adapted for continuous wear. The system is also adaptable or applicable to calculating derivations of such parameters. A oxygen debt measuring embodiment is directed predicting an outcome in response to injury and illness. The technique allows for closed-loop resuscitation, early identification of illness and early corrective action.
    Type: Application
    Filed: November 20, 2009
    Publication date: September 27, 2012
    Inventors: David Andre, Kevin Ward, Nisang Vyas, Eric Teller, John M. Stivoric, Jonathan Farringdon, Scott K. Boehmke, Christopher Pacione, Raymond Pelletier, Kevin Ross, Scott Safier, Suresh Vishnubhatla, Gregory Kovacs, James Gasbarro, Christopher Kasabach
  • Patent number: 8275432
    Abstract: An implantable optical sensor and associated manufacturing method include a sensor housing having an inner surface and an outer surface and a window formed in the housing extending between the housing inner surface and the housing outer surface. An opto-electronic device enclosed within the housing and having a photonic surface is operatively positioned proximate the window for emitting light through the window or detecting light through the window. An optical coupling member is positioned between the opto-electronic device and the window for reducing light reflection at a surface within the implantable optical sensor.
    Type: Grant
    Filed: December 12, 2007
    Date of Patent: September 25, 2012
    Assignee: Medtronic, Inc.
    Inventors: Jonathan L. Kuhn, Timothy J. Davis, Can Cinbis, Robert M. Ecker, Shawn D. Knowles, Thomas A. Anderson, Jeffrey M. Jelen
  • Patent number: 8275433
    Abstract: A non-invasive blood constituents measuring instrument measures blood constituent values including blood glucose concentration in a living body non-invasively. The instrument is composed of a light source 11 to irradiate a light containing plural wavelengths to a living body 13, a light receiver 14 to detect the light transmitted through a living body or reflected and scattered thereon, a spectrum analyzer 15 to analyze the light transmitted through the living body or reflected thereon at different times, a subtraction processor 18 to generate spectrum subtraction from the spectrum of the light at the different times measured by the spectrum analyzer 15, and a blood glucose concentration predictor 21 into which the output data of the subtraction processor 18 are input and which outputs a blood constituent value.
    Type: Grant
    Filed: June 26, 2007
    Date of Patent: September 25, 2012
    Assignee: yu.sys.corporation
    Inventor: Ken-ichi Yamakoshi
  • Publication number: 20120238842
    Abstract: An implantable device with in vivo functionality, where the functionality of the device is negatively affected by ROS typically associated with inflammation reaction as well as chronic foreign body response as a result of tissue injury, is at least partially surrounded by a protective material, structure, and/or a coating that prevents damage to the device from any inflammation reactions. The protective material, structure, and/or coating is a biocompatible metal, preferably silver, platinum, palladium, gold, manganese, or alloys or oxides thereof that decomposes reactive oxygen species (ROS), such as hydrogen peroxide, and prevents ROS from oxidizing molecules on the surface of or within the device. The protective material, structure, and/or coating thereby prevents ROS from degrading the in vivo functionality of the implantable device.
    Type: Application
    Filed: March 15, 2012
    Publication date: September 20, 2012
    Applicant: SENSORS FOR MEDICINE AND SCIENCE, INC.
    Inventors: Arthur E. Colvin, JR., Hui Jiang
  • Publication number: 20120238840
    Abstract: A substance component detection device includes a sensor substrate which is provided inside a concave groove, in which when an opening is closed by a measurement-target skin to form a closed space, and includes a projection group having a plurality of projections, a light source section which emits light toward the projection group, and light-receiving section which detects Raman scattering light generated by the projection group.
    Type: Application
    Filed: March 9, 2012
    Publication date: September 20, 2012
    Applicant: SEIKO EPSON CORPORATION
    Inventor: Nobuaki HASHIMOTO
  • Publication number: 20120238838
    Abstract: Systems, devices, methods, and compositions are described for providing real-time monitoring of cerebrospinal fluid for markers of progressive conditions.
    Type: Application
    Filed: March 17, 2011
    Publication date: September 20, 2012
    Inventors: Roderick A. Hyde, Sharon L. Wolda, Lowell L. Wood, JR.
  • Publication number: 20120238839
    Abstract: Systems, devices, methods, and compositions are described for providing real-time monitoring of cerebrospinal fluid for markers of progressive conditions.
    Type: Application
    Filed: March 17, 2011
    Publication date: September 20, 2012
    Inventors: Roderick A. Hyde, Sharon L. Wolda, Lowell L. Wood, JR.
  • Publication number: 20120238837
    Abstract: Systems, devices, methods, and compositions are described for providing real-time monitoring of cerebrospinal fluid for markers of progressive conditions.
    Type: Application
    Filed: March 16, 2011
    Publication date: September 20, 2012
    Inventors: Roderick A. Hyde, Sharon L. Wolda, Lowell L. Wood,, JR.
  • Publication number: 20120232363
    Abstract: Embodiments of the present disclosure include a handheld multi-parameter patient monitor capable of determining multiple physiological parameters from the output of a light sensitive detector capable of detecting light attenuated by body tissue. For example, in an embodiment, the monitor is capable of advantageously and accurately displaying one or more of pulse rate, plethysmograph data, perfusion quality, signal confidence, and values of blood constituents in body tissue, including for example, arterial carbon monoxide saturation (“HbCO”), methemoglobin saturation (“HbMet”), total hemoglobin (“Hbt”), arterial oxygen saturation (“SpO2”), fractional arterial oxygen saturation (“SpaO2”), or the like. The monitor can determine which a plurality of light emitting sources and which of a plurality of parameters to measure based on the signal quality and resources available.
    Type: Application
    Filed: May 22, 2012
    Publication date: September 13, 2012
    Applicant: CERCACOR LABORATORIES, INC.
    Inventors: Ammar Al-Ali, Joe E. Kiani, Mohamed Diab, Roger Wu, Rick Fishel
  • Publication number: 20120232362
    Abstract: Disclosed is an apparatus for analyzing the composition of bodily fluid. The apparatus can include a fluid handling network including a patient end configured to maintain fluid communication with a bodily fluid in a patient and a pump unit in operative engagement with the fluid handling network. The pump unit can have an infusion mode, in which the pump unit is operable to deliver infusion fluid to the patient through the patient end, and a sample draw mode, in which the pump unit is operable to draw a sample of the bodily fluid from the patient through the patient end. The apparatus can include a spectroscopic analyzer positioned to analyze at least a portion of the sample; a processor in communication with or incorporated into the spectroscopic analyzer; and stored program instructions executable by the processor to obtain measurements of two or more properties of the sample.
    Type: Application
    Filed: March 16, 2012
    Publication date: September 13, 2012
    Inventors: Jennifer H. Gable, James R. Braig, Kenneth I. Li, Mark Wechsler, Peng Zheng, Richard Keenan
  • Patent number: 8265724
    Abstract: There is provided a system and method for canceling shunted light. The method includes transmitting electromagnetic radiation at tissue of interest and generating a signal representative of detected electromagnetic radiation. A portion of the generated signal representing shunted light is canceled from the generated signal and the remaining portion of the generated signal is used to compute physiological parameters.
    Type: Grant
    Filed: March 9, 2007
    Date of Patent: September 11, 2012
    Assignee: Nellcor Puritan Bennett LLC
    Inventor: Ethan Petersen
  • Patent number: 8265723
    Abstract: An embodiment of the present disclosure seeks to select characteristics of incoming intensity data that cause comparisons of selected characteristics to produce defined probe off space having reduced crossover with defined probe on space. Once defined, the present disclosure compares characteristics of incoming intensity data with the now defined probe off space, and in some embodiments, defined probe on space, to determine whether a probe off condition exists. When a processor determines a probe off condition exists, the processor may output or trigger an output signal that audibly and/or visually indicates to a user that the optical sensor should be adjusted for a proper application to a measurement site.
    Type: Grant
    Filed: October 12, 2007
    Date of Patent: September 11, 2012
    Assignee: Cercacor Laboratories, Inc.
    Inventors: Ryan Timothy McHale, Walter M. Weber
  • Publication number: 20120226116
    Abstract: A bodily fluid sampling device includes a piercing device and a sensor enclosed in a housing. A cassette, which contains test media, is positioned proximal to the sensor so that the sensor is able to analyze a bodily fluid sample collected on the test media. The cassette includes a supply portion from which unused test media is supplied and a storage portion in which contaminated test media is stored after exposure to the bodily fluid. The cassette is adapted to collect a series of bodily fluid samples without requiring disposal of the test media.
    Type: Application
    Filed: May 8, 2012
    Publication date: September 6, 2012
    Applicant: Roche Diagnostics Operations Inc.
    Inventors: Jeffrey N. Roe, Steven N. Roe
  • Publication number: 20120226118
    Abstract: A sensor is described for sensing a substance such as for example glucose. The sensor is implantable in the body of a living creature. The sensor comprises a photonic integrated circuit, e.g. silicon-photonics, based radiation processor for spectrally processing radiation interacting with the sample. A continuous monitoring system also is described using such a sensor.
    Type: Application
    Filed: March 8, 2012
    Publication date: September 6, 2012
    Inventors: Danaë DELBEKE, Roel BAETS, Wim BOGAERTS, Eva Maria Paula RYCKEBOER
  • Patent number: 8260389
    Abstract: Bladder function monitoring methods, apparatuses, media and signals are disclosed. A method includes receiving signals from an electromagnetic radiation detector, the signals representing electromagnetic radiation detected from the bladder during irradiance of the bladder with electromagnetic radiation, and further includes storing data indicative of bladder function, in response to the signals. The received signals may represent near infrared (NIR) detected from the bladder during NIR irradiance of the bladder.
    Type: Grant
    Filed: April 13, 2006
    Date of Patent: September 4, 2012
    Assignee: Hegln (Dalian) Pharmaceuticals, Inc.
    Inventors: Lynn Stothers, Roy E. Gagnon, Andrew J. MacNab
  • Publication number: 20120220839
    Abstract: A prosthetic component suitable for long-term implantation is provided. The prosthetic component includes electronic circuitry and sensors to measure a parameter of the muscular-skeletal system. The prosthetic component comprises a first structure having at least one support surface, a second structure having at least one feature configured to couple to bone, and at least one sensor. The electronic circuitry and sensors are hermetically sealed within the prosthetic component. One or more sensors can be used to monitor synovial fluid in proximity to the joint to determine joint health. The prosthetic component includes a transmissive region. One or more optical sensors are mounted in proximity to the transmissive region. Periodic measurements of the synovial fluid are measured through the transmissive region. The measurements can include color and turbidity of the synovial fluid. The color and turbidity data can be compared against known data to determine joint status.
    Type: Application
    Filed: February 27, 2012
    Publication date: August 30, 2012
    Applicant: ORTHOSENSOR
    Inventors: Marc Stein, Andrew Chase
  • Patent number: 8255026
    Abstract: A system and method to help maintain quality control and reduce cannibalization of accessories and attached probes in a highly sensitive patient monitor, such as a pulse oximetry system. One or more attached components may have information elements designed to designate what quality control mechanisms a patient monitor should look to find on that or another component or designate other components with which the one component may properly work. In a further embodiment, such information elements may also include data indicating the appropriate life of the component.
    Type: Grant
    Filed: October 12, 2007
    Date of Patent: August 28, 2012
    Assignee: Masimo Corporation, Inc.
    Inventor: Ammar Al-Ali
  • Patent number: 8255029
    Abstract: A physiological measurement system is disclosed which can take a pulse oximetry signal such as a photoplethysmogram from a patient and then analyse the signal to measure physiological parameters including respiration, pulse, oxygen saturation and movement. The system can be used as a general monitor, or more specifically, to for infant or adult apnea, and to guard against sudden infant death syndrome.
    Type: Grant
    Filed: February 27, 2004
    Date of Patent: August 28, 2012
    Assignee: Nellcor Puritan Bennett LLC
    Inventors: Paul Stanley Addison, James Nicholas Watson
  • Patent number: 8255051
    Abstract: An exemplary method includes emitting radiation subcutaneously; sensing at least some of the emitted radiation as reflected cutaneously; detecting an abnormal physiologic condition; and, based at least in part on the sensing, adjusting a stimulation therapy to treat the detected abnormal condition. In such a method, the abnormal condition may be an abnormal cardiac condition, an abnormal neural condition or other condition. Various other methods, devices, systems, etc., are also disclosed.
    Type: Grant
    Filed: May 19, 2010
    Date of Patent: August 28, 2012
    Assignee: Pacesetter, Inc.
    Inventor: Martin Cholette
  • Patent number: 8255027
    Abstract: A physiological sensor has emitters configured to transmit optical radiation having multiple wavelengths in response to corresponding drive currents. A thermal mass is disposed proximate the emitters so as to stabilize a bulk temperature for the emitters. A temperature sensor is thermally coupled to the thermal mass. The temperature sensor provides a temperature sensor output responsive to the bulk temperature so that the wavelengths are determinable as a function of the drive currents and the bulk temperature.
    Type: Grant
    Filed: July 19, 2010
    Date of Patent: August 28, 2012
    Assignee: Cercacor Laboratories, Inc.
    Inventors: Ammar Al-Ali, Mohamed Diab, Marcelo Lamego, James P. Coffin, Yassir Abdul-Hafiz
  • Patent number: 8255025
    Abstract: The disclosure provides a sensor system for detecting bronchial tissular water content including at least a sensor, a connector, and a monitor. The sensor generates a signal, which may be carried by the connector to the monitor, which generates an output corresponding to the signal. The disclosure additionally provides a sensor for detecting bronchial or tracheal tissular water content including at least a signal generator. The sensor may also include at least a segment of a connector. The disclosure also provides a method of measuring bronchial or tracheal tissular water content by inserting a sensor into an airway of a subject, such as a human, until it becomes lodged in a bronchus or the trachea, then measuring bronchial or tracheal tissular water content using the sensor.
    Type: Grant
    Filed: June 9, 2006
    Date of Patent: August 28, 2012
    Assignee: Nellcor Puritan Bennett LLC
    Inventor: Diana Villegas
  • Publication number: 20120215078
    Abstract: One of the purposes of the present invention is to provide a biogenic substance concentration measuring method with improved measuring accuracy. An embodiment of the present invention provides a method for measuring a concentration of a biogenic substance contained in a living body, the method comprises steps of preparing a measuring device, wherein the measuring device comprises a light source, an optical filter, and a light receiver; irradiating a substantially-parallel light from the light source onto a particle chip implanted in a skin though a position on the surface of the skin to generate a reflected light; inclining the light source and calculating the concentration of the biogenic substance on the basis of the difference of signals before and after the inclination.
    Type: Application
    Filed: April 27, 2012
    Publication date: August 23, 2012
    Applicant: Panasonic Corporation
    Inventors: Tatsurou KAWAMURA, Masaru Minamiguchi, Masahiko Shioi
  • Patent number: 8249682
    Abstract: A medical diagnostic method utilizes a surface plasmon resonance apparatus provided with a sensing surface. A tear sample from an eye of a patient is placed into contact with the sensing surface. The surface plasmon resonance apparatus is then operated to determine concentrations of solutes such as salt and antigenic analytes in the tear sample.
    Type: Grant
    Filed: September 6, 2007
    Date of Patent: August 21, 2012
    Assignee: Lacrisciences, LLC
    Inventors: Anthony P. Cappo, Gregory Bennett, Jeffrey P Gilbard, Paul T Gavaris, Diptabhas Sarkar
  • Patent number: 8249681
    Abstract: Devices, systems and method for in vivo analysis. For example, an in vivo device includes: a reaction chamber to store a detecting reagent able to react with a sample collected in vivo; and optionally a labeled-substance chamber to store a labeled substance able to bind to at least a portion of a compound resulting from a reaction of the detecting reagent and the sample.
    Type: Grant
    Filed: January 31, 2006
    Date of Patent: August 21, 2012
    Assignee: Given Imaging Ltd.
    Inventor: Elisha Rabinovitz
  • Publication number: 20120209092
    Abstract: In a non-invasive human metabolic condition measuring apparatus and method, a micro-light source emits an incident light having a wavelength from 329 nm to 473 nm to trigger a mitochondrial metabolite of a human mucosa tissue, and the metabolite is excited to generate a fluorescent signal having a wavelength from 405 nm to 572 nm, and the fluorescent signal is filtered by an optical filter, received by a micro receiver, and amplified by an amplification circuit sequentially, and then a filter circuit and an analog/digital conversion circuit of a microprocessing unit are provided for filtering and performing an analog/digital signal conversion respectively, so that the metabolite content can be calculated by the computation to provide human metabolic conditions, and a combination of micro components and circuits is used for miniaturizing the apparatus to provide a convenient carry of the apparatus.
    Type: Application
    Filed: February 16, 2011
    Publication date: August 16, 2012
    Applicant: SOUTHERN TAIWAN UNIVERSITY
    Inventors: JENQ-RUEY HORNG, SHOKO NIOKA, CHI-JO WANG, CHIH-CHIEH KANG, JUING-SHIAN CHIOU, SHIH-CHUNG CHEN, CHIH-KUO LIANG, CHING-LUNG CHU, HUNG-CHI YANG, LIAN-JOU TSAI, TSUNG-FU JENG
  • Publication number: 20120209093
    Abstract: A method for detecting a virus in a patient based on imaging data includes scanning a region of interest of the patient with an imaging device and generating imaging data indicative of the region of interest, identifying at least one marker in the image data that corresponds to the virus based on the identified at least one marker and a set of predetermined imageable markers that correspond to the virus, classifying the virus as a particular strain of the virus based on a set of classification rules, and generating a signal indicative of the particular strain. The method optionally includes generating a signal indicative of the classification and electronically conveying the signal to at least one entity.
    Type: Application
    Filed: October 29, 2010
    Publication date: August 16, 2012
    Applicant: KONINKLIJKE PHILIPS ELECTRONICS N.V.
    Inventors: Mark E. Olszewski, Matthew J. Walker
  • Patent number: 8244324
    Abstract: An optical measurement instrument for a living body having an optical fiber removed, which is composed so as to transmit a driving signal for the light source to a plurality of an irradiation parts, as well as to convert a transmitted and received signal, between a processing and control unit and the probe unit, to a row of serial digital signals, by having one driving device for light source and one multiplexer, inside the probe unit.
    Type: Grant
    Filed: November 16, 2007
    Date of Patent: August 14, 2012
    Assignee: Hitachi, Ltd.
    Inventors: Hirokazu Atsumori, Masashi Kiguchi, Tadahiro Horita
  • Patent number: 8244332
    Abstract: A diffuse optical spectroscopy system comprises a laser breast scanner, a handheld probe connected to the laser breast scanner for scanning a breast, and a tracking device coupled to the handheld probe, wherein the tracking device determines locations of the handheld probe relative to the breast. The tracking device comprises a magnetic tracking device, an optical tracking device or a laser tracking device.
    Type: Grant
    Filed: December 1, 2005
    Date of Patent: August 14, 2012
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Fred S. Azar, Ali Khamene, Frank Sauer, Bruce Tromberg, Albert Cerussi
  • Patent number: 8244326
    Abstract: A probe device for optically measuring a condition of an object includes a light emitter for emitting a light to proceed into the object through a surface of the object, a light sensor for measuring an optical condition of the light proceeding from the surface through the object and subsequently emitted from the surface to reach the light sensor, and a body holding thereon at least one of the light emitter and the light sensor. The body includes at least one main protrusion protruding so as to face to the surface, and at least two sub-protrusions arranged around the at least one main protrusion and protruding so as to face to the surface.
    Type: Grant
    Filed: November 15, 2007
    Date of Patent: August 14, 2012
    Assignee: Hitachi, Ltd.
    Inventors: Atsushi Ninomiya, Yoshimi Kasai, Yukiko Hirabayashi
  • Publication number: 20120203086
    Abstract: Apparatus and methods for spectroscopic analysis of biological tissues to classify an individual as diabetic or non-diabetic, or to determine the probability, progression or level of a disease or medical condition in an individual.
    Type: Application
    Filed: November 7, 2011
    Publication date: August 9, 2012
    Applicant: FREEDOM MEDITECH, INC.
    Inventors: Dale A. RORABAUGH, Neil M. DAVIS, Vincent F. BRANCACCIO, Paul WILLIAMS
  • Publication number: 20120203085
    Abstract: A system for determining an analyte concentration in a fluid sample (e.g., glucose) comprises a light source, a detector, and a central processing unit. The detector is adapted to receive spectral information corresponding to light returned from the fluid sample being analyzed and to convert the received spectral information into an electrical signal indicative of the received spectral information. The central processing unit is adapted to compare the electrical signal to an algorithm built upon correlation with the analyte in body fluid. The algorithm is adapted to convert the received spectral information into the analyte concentration in body fluid. Spectral information is delivered from the central processing unit to the light source and used to vary the intensity and timing of the light to improve the accuracy of conversion into analyte concentration.
    Type: Application
    Filed: April 13, 2012
    Publication date: August 9, 2012
    Applicant: BAYER HEALTHCARE LLC
    Inventor: Mihailo V. Rebec
  • Patent number: 8238993
    Abstract: A method of determining a measure of a tissue state (e.g., glycation end-product or disease state) in an individual. A portion of the tissue of the individual is illuminated with excitation light, then light emitted by the tissue due to fluorescence of a chemical with the tissue responsive to the excitation light is detected. The detected light can be combined with a model relating fluorescence with a measure of tissue state to determine a tissue state. The invention can comprise measuring the fluorescence lifetime in either time-domain or frequency domain modes. The invention can also comprise a variety of models relating fluorescence to a measure of tissue state, including a variety of methods for generating such models. For example, multivariate models can be developed that relate lifetime trends of one or more constituents to increasing propensity to diabetes and pre-diabetes.
    Type: Grant
    Filed: December 19, 2007
    Date of Patent: August 7, 2012
    Assignee: VeraLight, Inc.
    Inventors: John D Maynard, Marwood Neal Ediger
  • Publication number: 20120197096
    Abstract: An apparatus and method for noninvasive determination of analyte properties of human tissue by quantitative infrared spectroscopy to clinically relevant levels of precision and accuracy. The system includes subsystems optimized to contend with the complexities of the tissue spectrum, high signal-to-noise ratio and photometric accuracy requirements, tissue sampling errors, calibration maintenance problems, and calibration transfer problems. The subsystems can include an illumination/modulation subsystem, a tissue sampling subsystem, a data acquisition subsystem, a computing subsystem, and a calibration subsystem. The invention can provide analyte property determination and identity determination or verification from the same spectroscopic information, making unauthorized use or misleading results less likely than in systems that use separate analyte and identity determinations. The invention can be used to control and monitor individuals accessing controlled environments.
    Type: Application
    Filed: April 12, 2012
    Publication date: August 2, 2012
    Inventors: Trent Ridder, Ben Ver Steeg, Oscar Lazaro
  • Patent number: 8233968
    Abstract: An infrared imaging camera (4) acquires a plurality of frames (94) of infrared radiation from a patient (P) positioned in a field-of-view (92) of the camera (4). Each frame (94) is acquired during a corresponding frame sample interval and each frame (94) corresponds to the infrared radiation acquired from an array of optical elements (90) in the field-of-view (92) during its frame sample interval. Plural rates of change are determined from infrared radiation received from the array of optical elements (90), with each rate of change corresponding to a change of infrared radiation received from the same optical element (90) in at least two frames (94). Each rate of change is mapped to a color or a shade of gray and the color or shade of gray of each rate of change is mapped to a position in an image corresponding to the position of the corresponding optical element (90) in the field-of-view (92).
    Type: Grant
    Filed: June 20, 2000
    Date of Patent: July 31, 2012
    Assignee: Victor John Yannacone, Jr.
    Inventors: Victor John Yannacone, Jr., Carol A. Yannacone, Benjamin A. Rousseau, Jacob Green, William B. Hobbins